CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Treatment of bacterial respiratory infections in lambs
Authors
Vasileiou N.G.C., Ioannidi K.S., Mavrogianni V.S. Politis A.P.
Publication date
1 January 2019
Publisher
'Elsevier BV'
Doi
Cite
Abstract
Objective of the present paper is to discuss treatment of bacterial respiratory infections in lambs. This should aim to control clinical signs, as well as to limit lesions in the lungs of the affected animals, and requires immediate action with mainly antimicrobial agents effective against the causal bacteria. In clinical practice, correct identification of affected lambs is important for administration of the appropriate treatment regime. Fluoroquinolones, tilmicosin, tulathromycin, chlortetracycline, doxycycline and oxytetracycline are effective against both Mannheimia haemolytica and Mycoplasma, which are the major causal agents of respiratory infections of lambs. Simultaneous administration of non-steroid anti-inflammatory drugs is also recommended. All lambs with clinical signs must undergo the full treatment schedule. The potential value of a metaphylactic treatment in clinically healthy lambs, within flocks with affected animals, should be assessed on a case-by-case basis. Treatment protocols of the disease should always include management changes in the flock to eliminate factors that contribute to development of the disease. © 2019 Elsevier B.V
Similar works
Full text
Available Versions
University of Thessaly Institutional Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:ir.lib.uth.gr:11615/78292
Last time updated on 13/02/2023